Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Bacterial Infections and Mycoses

Free Subscription 26.10.2026 1 Am J Respir Crit Care Med 1 Ann Intern Med 4 Antimicrob Agents Chemother 3 BMC Pediatr 1 Clin Infect Dis 6 Curr Microbiol 2 Diagn Microbiol Infect Dis 18 Eur J Clin Microbiol Infect Dis 3 J Antimicrob Chemother 1 J Bacteriol 5 J Med Chem 1 J Med Microbiol 4 N Engl J Med 2 PLoS Biol 1 PLoS Med 3 PLoS Negl Trop Dis 3 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. LIU K, Chen B, Li T, Zheng A, et al
   Serial Mass Tuberculosis Screening Among the Elderly in Eastern China from 2021-2023.
   Am J Respir Crit Care Med. 2026 Oct 20:aamag564. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. MAKI DG
   In methicillin-susceptible S aureus bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin for 90-d mortality.
   Ann Intern Med. 2026;179:JC110.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

3. MANN CA, West JS, Cassel SR, Wheat CT, et al
   In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infections.
   Antimicrob Agents Chemother. 2026 Oct 22:e0069826. doi: 10.1128/aac.00698.
   PubMed         Abstract available
   
   
4. WOISCHNIG A-K, Kuehl R, Cornillet D, Iizuka A, et al
   Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinations.
   Antimicrob Agents Chemother. 2026 Oct 21:e0087626. doi: 10.1128/aac.00876.
   PubMed         Abstract available
   
   
5. GARCIA-EFFRON G
   Foundational evidence of CYP51 isozyme selectivity and azole synergy in Aspergillus fumigatus.
   Antimicrob Agents Chemother. 2026 Oct 20:e0080426. doi: 10.1128/aac.00804.
   PubMed        
   
   
6. ISHII M, Ohata S
   Reply to Garcia-Effron, "Foundational evidence of CYP51 isozyme selectivity and azole synergy in Aspergillus fumigatus".
   Antimicrob Agents Chemother. 2026 Oct 20:e0083826. doi: 10.1128/aac.00838.
   PubMed        
   
   

   
   BMC Pediatr

7. BURNHAM L, Lichstein W, Lyford A
   Maternal risk factors associated with neonatal necrotizing enterocolitis: a meta-analysis and systematic review.
   BMC Pediatr. 2026;26:1048.
   PubMed         Abstract available
   
   
8. GIRMAY TG, Gossaye TY, Gebrihiet HH, Tsegay N, et al
   Retrospective cross-sectional study of clinical and laboratory profiles of paediatric tuberculosis at Ayder Comprehensive Specialized Hospital, Ethiopia (2018-2021).
   BMC Pediatr. 2026;26:1029.
   PubMed         Abstract available
   
   
9. JIANLONG C, Yingying Y, Zhiling Z, Weifang Z, et al
   Development of a nomogram for risk factors of wheezing in infants with Mycoplasma pneumoniae pneumonia.
   BMC Pediatr. 2026;26:1027.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. SINGH UB, DiBona K, Shaikh S, Mattoo SK, et al
    Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort.
    Clin Infect Dis. 2026 Oct 19:ciag677. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Microbiol

11. WU C, Yang X, Yu W
    Global Distribution and Co-occurrence of Antimicrobial, Biocide, and Metal Resistance Genes in 11,921 Acinetobacter baumannii Genomes.
    Curr Microbiol. 2026;83:596.
    PubMed         Abstract available
    
    
12. WANG Z, Lin J, Zhang X, Yang J, et al
    Molecular Detection Technologies for Helicobacter pylori Antibiotic Resistance: Current Status and Clinical Implications.
    Curr Microbiol. 2026;83:598.
    PubMed         Abstract available
    
    
13. REZK S, Fawzy N, Elsheredy A, Mansour RE, et al
    Inoculum Effect in Multidrug-Resistant Gram-Negative Isolates: Impact on Ceftazidime and Cefepime Susceptibility.
    Curr Microbiol. 2026;83:605.
    PubMed         Abstract available
    
    
14. SOUZA TAM, de O Mello E, Trindade FG, Moreira FF, et al
    In Vitro Activity and Synergism of Amphotericin B and the Synthetic Bioinspired Peptide (gamma31-45)PvD(1)(++) Against Fungal Study Models Candida tropicalis and Saccharomyces cerevisiae.
    Curr Microbiol. 2026;83:608.
    PubMed         Abstract available
    
    
15. CARNEIRO VA, Azevedo AMA, da Silva BF, Melo RS, et al
    Eugenol Activity Against Escherichia coli and Staphylococcus aureus: Biofilm Disruption and Additive Interactions with Antibiotics.
    Curr Microbiol. 2026;83:611.
    PubMed         Abstract available
    
    
16. ESKILDSEN MH, Ostergaard SK, Menanteau-LeDouble S, Pagh S, et al
    Differentially Expressed Infection-Associated Genes in a Shewanella algae isolate From a Deceased Northern Bottlenose Whale.
    Curr Microbiol. 2026;83:610.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

17. SON ES, Lee SY, Lee MJ, Kang S, et al
    Analytical and clinical performance evaluation of the STANDARD M10 MTB/NTM assay for the simultaneous detection of Mycobacterium tuberculosis and nontuberculous mycobacteria.
    Diagn Microbiol Infect Dis. 2026;117:117692.
    PubMed         Abstract available
    
    
18. MUQTADIR J, Batool I, Akhtar A, Bhatti S, et al
    Disseminated MDR tuberculosis manifesting as Pott's disease with tuberculous septic ankle arthritis: an uncommon sequential dual-site involvement.
    Diagn Microbiol Infect Dis. 2026;117:117685.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

19. FUMAGALLI G, Riccardi N, Nadalin M, Puci M, et al
    Predictors of treatment initiation in nontuberculous mycobacterial pulmonary disease: a real-life retrospective analysis.
    Eur J Clin Microbiol Infect Dis. 2026;45:3229-3233.
    PubMed         Abstract available
    
    
20. CHEN J, Liu X, Huang X, Huang M, et al
    Probiotic-associated Bacillus subtilis subsp. subtilis catheter-related bloodstream infection in a preterm infant: a caution for neonatal intensive care units.
    Eur J Clin Microbiol Infect Dis. 2026;45:3251-3255.
    PubMed         Abstract available
    
    
21. VERMA S, Kuntal K, Deep H, Venkatesh V, et al
    Aeromonas dhakensis as an emerging invasive pathogen: a case series highlighting distinct carbapenem resistance and diagnostic challenge.
    Eur J Clin Microbiol Infect Dis. 2026;45:3019-3026.
    PubMed         Abstract available
    
    
22. RONNINGEN TK, Gran FW, Damas JK, Afset JE, et al
    In-depth analysis of sampling practice and yield of blood cultures.
    Eur J Clin Microbiol Infect Dis. 2026;45:3027-3036.
    PubMed         Abstract available
    
    
23. BAKHIET S, Siddig E, Minlekib CP, Mohammed R, et al
    A qPCR identification scheme to differentiate actinomycetoma from eumycetoma.
    Eur J Clin Microbiol Infect Dis. 2026;45:3045-3055.
    PubMed         Abstract available
    
    
24. KUMAR A, Kumar A, Tyagi A, Singh R, et al
    A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.
    Eur J Clin Microbiol Infect Dis. 2026;45:2939-2987.
    PubMed         Abstract available
    
    
25. CALLEBAUT K, Chin T, Hellemans J, Muyldermans A, et al
    Consensus-based evaluation of RIDASCREEN((R)) TB ELISA compared with two interferon-gamma release assays in a low-incidence setting.
    Eur J Clin Microbiol Infect Dis. 2026;45:3095-3102.
    PubMed         Abstract available
    
    
26. DUTARTE M, Genestet C, Lina G, Dumitrescu O, et al
    Nocardia antimicrobial susceptibility testing by microdilution: evaluation of ready-to-use plate including tedizolid and meropenem.
    Eur J Clin Microbiol Infect Dis. 2026;45:3103-3115.
    PubMed         Abstract available
    
    
27. MAHAMUD SMI, Sahim M, Sanam M, Oishi JF, et al
    Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization.
    Eur J Clin Microbiol Infect Dis. 2026;45:3117-3133.
    PubMed         Abstract available
    
    
28. ABASSI S, Boujemaa S, Chniba I, Zidi S, et al
    MUREAPLEXE: A multiplex recombinant antigen-based ELISA expanding the serological detection spectrum of urogenital mycoplasmas.
    Eur J Clin Microbiol Infect Dis. 2026;45:3135-3148.
    PubMed         Abstract available
    
    
29. ALMELA-FERRER MDR, Nieto-Toboso MC, Montoya-Azpeitia E, Lopez-de Munain J, et al
    Molecular epidemiology and pharmacokinetic-pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain.
    Eur J Clin Microbiol Infect Dis. 2026;45:3169-3180.
    PubMed         Abstract available
    
    
30. XU X, Lu E, Wu L
    Performance evaluation of antimicrobial susceptibility testing methods for ceftazidime-avibactam and imipenem-relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Eur J Clin Microbiol Infect Dis. 2026;45:3159-3167.
    PubMed         Abstract available
    
    
31. ENDO A, Hanai Y, Mikawa T, Asakawa D, et al
    Impact of a pharmacist-led infectious disease support team on candidemia bundle adherence and 28-day mortality: a single-center retrospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2026;45:3193-3203.
    PubMed         Abstract available
    
    
32. DE LUCENA TS, Galani LC, Barbosa LD, Dias GF, et al
    Hidden burden of leprosy in incarcerated populations in northeast Brazil: active case detection and serological assessment.
    Eur J Clin Microbiol Infect Dis. 2026;45:3205-3215.
    PubMed         Abstract available
    
    
33. COTOS SUAREZ A, Lopez-Bernus A, Alonso-Sardon M, Velasco Tirado V, et al
    Clinical predictors, microbiological profile, and outcomes of bacteremia in patients with cellulitis: a 6-year retrospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2026;45:2989-3002.
    PubMed         Abstract available
    
    
34. VALSECCHI P, Colaneri M, Lombardi A, Biscarini S, et al
    Is less always more? Ceftazidime/avibactam alone or in combination to treat infections caused by Pseudomonas aeruginosa: a retrospective observational multi-centre cohort study.
    Eur J Clin Microbiol Infect Dis. 2026;45:3217-3227.
    PubMed         Abstract available
    
    
35. WU H, Jiang F, Tian S
    Research progress on detection technologies for Mycoplasma pneumoniae.
    Eur J Clin Microbiol Infect Dis. 2026;45:3003-3017.
    PubMed         Abstract available
    
    
36. FUKUDA Y, Togashi A, Aung MS, Takahashi H, et al
    ST20 Staphylococcus aureus causing suppurative cervical lymphadenitis in an extremely low-birth-weight infant.
    Eur J Clin Microbiol Infect Dis. 2026 Oct 17. doi: 10.1007/s10096-026-05699.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

37. CANDEL FJ, Matesanz M, Munoz-Gomez A, Del Pozo JL, et al
    Cross-susceptibility among tetracyclines in Gram-positive infections: microbiological basis, EUCAST/CLSI guidance and clinical implications for doxycycline use.
    J Antimicrob Chemother. 2026;81:dkag353.
    PubMed         Abstract available
    
    
38. SVENSSON S, Jacobsson S, Matuschek E, Soderquist B, et al
    In vitro susceptibility of Cutibacterium acnes to dalbavancin: comparison between gradient test and the agar dilution reference method.
    J Antimicrob Chemother. 2026;81:dkag364.
    PubMed         Abstract available
    
    
39. LUO H, Ye T
    Comment on: 'Acute kidney injury in Staphylococcus aureus bacteremia: a multicentre cohort study of incidence, timing, recovery, and associations with antibiotic treatment'.
    J Antimicrob Chemother. 2026;81:dkag366.
    PubMed        
    
    

    
    J Bacteriol

40. JANET-MAITRE M, Feldman MF
    A minimalist opportunist: the emergence of Acinetobacter baumannii.
    J Bacteriol. 2026;208:e0036026.
    PubMed         Abstract available
    
    

    
    J Med Chem

41. FANG J, Meng L, Hong S, Zhang J, et al
    Leveraging the Iron-Probe-MurB Interaction: An Enhanced Platform for PET Imaging of Bacterial Infections.
    J Med Chem. 2026;69:21777-21788.
    PubMed         Abstract available
    
    
42. LIN S, Zhang Q, Tan S, Lou L, et al
    Phenothiazine-Driven Autophagic Response in Macrophages as an Anti-cutaneous Tuberculosis Approach.
    J Med Chem. 2026;69:22355-22369.
    PubMed         Abstract available
    
    
43. LOBANOV V, Lupien A, Vocat A, Singh R, et al
    Antivirulence Benzothiophenes Inhibit Intracellular Mycobacterium tuberculosis by Targeting the Sensor Histidine Kinase MprB.
    J Med Chem. 2026;69:23968-23990.
    PubMed         Abstract available
    
    
44. GAO Z, Hao W, Cui C, Chen M, et al
    Design, Synthesis, and Biological Evaluation of Novel Tetrazole-Containing Tetrahydroisoquinoline Derivatives as Putative CYP51 Inhibitors against Candida Species.
    J Med Chem. 2026;69:23810-23834.
    PubMed         Abstract available
    
    
45. KUSHWAHA R, Chakraborty D, Mandal A, Upadhyay A, et al
    Re(I)-BODIPY Photosensitizer for Infected Wound Healing in the Rat Model under Green Light.
    J Med Chem. 2026;69:23706-23722.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

46. MARTARESCHE C, Scherrer F
    Evaluation of the Hologic Aptima((R)) Vaginitis and Seegene Allplex() assays for microbiological diagnosis of bacterial vaginosis and Candida vaginitis in women in France, relative to Nugent score and culture.
    J Med Microbiol. 2026;75:002210.
    PubMed         Abstract available
    
    

    
    N Engl J Med

47. DESIMONE DC, Baddour LM
    Infective Endocarditis - When Is Enough Enough?
    N Engl J Med. 2026;395:1647-1648.
    PubMed        
    
    
48. SOLEIMANI A, Aghagoli Y
    Tuberculous Empyema Resulting in Pseudochylothorax.
    N Engl J Med. 2026;395:e23.
    PubMed        
    
    
49. LI H, Megraud F, Marshall BJ
    Helicobacter pylori Infection - Advances, Challenges, and the Road Ahead.
    N Engl J Med. 2026;395:1621-1633.
    PubMed         Abstract available
    
    
50. HENRIQUES SP, Mota M
    Spinal Tuberculosis.
    N Engl J Med. 2026;395:1634.
    PubMed        
    
    

    
    PLoS Biol

51. POTTON AM, Kalinina I, Brown GD, Makarova M, et al
    The Cryptococcus neoformans titanide is a pathogenic cell type that arises from typical yeast cells in response to host conditions.
    PLoS Biol. 2026;24:e3004031.
    PubMed         Abstract available
    
    
52. WANG Y, Tancer RJ, Wear M, Jackson KM, et al
    An inositol receptor Itr4 coordinates carbon catabolite regulation and virulence in Cryptococcus neoformans.
    PLoS Biol. 2026;24:e3003709.
    PubMed         Abstract available
    
    

    
    PLoS Med

53. WENGER CGC, Grantz KH, Menkir TF, Muellenmeister AM, et al
    Evaluating the impact and cost-effectiveness of typhoid conjugate vaccine schedules across diverse settings: A multi-model comparison.
    PLoS Med. 2026;23:e1005280.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

54. DELAHAYE A, Dequidt T, Quet F, Montagnac C, et al
    Clinical features and outcomes of neuroleptospirosis in French Guiana: Insights from a retrospective study (2015-2021).
    PLoS Negl Trop Dis. 2026;20:e0014263.
    PubMed         Abstract available
    
    
55. MUHIGI SA, Mashoto K, Chiduo M
    Barriers to biomedical care: Qualitative insights into health-seeking behaviors and systemic challenges among people affected by leprosy in Tanzanian communities.
    PLoS Negl Trop Dis. 2026;20:e0014806.
    PubMed         Abstract available
    
    
56. BASS A, Leite H, Oliveira LBP, Nedell E, et al
    Mycobacterium leprae infection, Hansen's disease, and helminth infections: A cross-sectional study in southeastern Brazil.
    PLoS Negl Trop Dis. 2026;20:e0013285.
    PubMed         Abstract available
    
    

    
    PLoS One

57. MESELE DW, Ayele L, Aman J, Alemayehu DH, et al
    The hidden burden of viral meningitis in ethiopia: Etiology and clinical outcomes.
    PLoS One. 2026;21:e0361291.
    PubMed         Abstract available
    
    
58. SANYA N, Vaccaro ME, Uppal M, Glen S, et al
    PREnatal Syphilis point-of-care ScreenING in an urban low-barrier clinic (PRESSING) study: Protocol for a prospective single arm feasibility trial.
    PLoS One. 2026;21:e0360150.
    PubMed         Abstract available
    
    
59. SIDDIKI AZ, Humaira N, Hossain NS, Akbar YB, et al
    Nomenclature, classification, and in-silico structural analysis of MSP1a variants of Anaplasma marginale.
    PLoS One. 2026;21:e0360505.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

60. JI Y, Zhang M, Song L, Ning H, et al
    Dual activities of lysis and capsule degradation enable the bacteriophage protein Lys33795 to effectively disrupt Streptococcus suis biofilms.
    PLoS Pathog. 2026;22:e1014741.
    PubMed         Abstract available
    
    
61. FAIRGRIEVE MR, Brydon EC, Chavez RA, Kotov DI, et al
    Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity.
    PLoS Pathog. 2026;22:e1014713.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. MARIN MG, Quinones-Olvera N, Jin H, Harris MA, et al
    Gene conversion is a key driver of diversity hotspots in Mycobacterium tuberculosis antigens and virulence-associated loci.
    Proc Natl Acad Sci U S A. 2026;123:e2607261123.
    PubMed         Abstract available
    
    

    
    Science

63. COHEN J
    How the domestication of a killer bacterium led to Botox.
    Science. 2026;394:367-368.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum